GOVX
GOVX
NASDAQ · Biotechnology

Geovax Labs Inc

$1.27
-0.01 (-0.78%)
As of Jun 30, 10:59 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +1,212.6% upside
Low Target $13.69
Average Target $16.67
High Target $25.88
Current Price $1.27
Current
$1.27
Target
$16.67
$13.69 $16.67 avg $25.88
Scenario Analysis
Bear Case
$13.69
978.0%
Low target
Base Case
$16.67
+1,212.6%
Avg target
Bull Case
$25.88
+1,937.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$24.50
-94.8% from high
52-Week Low
$0.96
+31.9% from low
Target vs 52W High
$16.67
-32.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%